Viewing Study NCT01829503


Ignite Creation Date: 2025-12-24 @ 7:43 PM
Ignite Modification Date: 2026-01-02 @ 7:16 AM
Study NCT ID: NCT01829503
Status: COMPLETED
Last Update Posted: 2019-11-14
First Post: 2013-03-06
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
Sponsor: Annie Im, M.D.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Myeloid Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase II View
None decitabine View
None cytarabine View
None older patients View
None newly diagnosed View
None AML View
None Newly Diagnosed AML View